What Dolormin (ibuprofen) Treats: Main Uses and Benefits

This medicine is broadly applied across domains where additional symptomatic support is needed, utilized to address symptoms related to systemic imbalance and physical discomfort. It is commonly used to provide symptomatic relief for mild to moderate acute pain, addressing sudden discomforts like headache, toothache, or backache.

Core Therapeutic Coverage

Dolormin is relevant in conditions involving inflammatory or irritative processes, as it helps manage symptoms related to inflammatory or irritative states, such as joint pain, muscle aches, tenderness, and localized swelling, characteristic of conditions like sprains, strains, or chronic arthritis. It is also applied to manage fever (elevated body temperature) and in specific episodic scenarios such as menstrual cramps (primary dysmenorrhea).

“The medicine provides support that helps ease the symptom load during difficult episodes.”

This supports general well-being during symptomatic phases and assists with maintaining functional stability. The medication is used across therapeutic contexts that require short-term symptom management and assistance with functional stability.

---

Quick Fact: Relief for Pain, Inflammation, and Fever

Property	Description
Primary Action	Triple-action relief (Pain, Fever, Inflammation)
Typical Severity	Mild to Moderate Pain, Acute Fever
Use Contexts	Episodic Pain, Musculoskeletal Injuries, Illness Symptoms
Patient Benefit	Supports stability and comfort during symptomatic phases

Regulatory References

1. MedlinePlus overview of Ibuprofen

Dolormin, which contains ibuprofen, has a defined eligibility profile set by regulatory authorities, classifying populations into allowed, conditional, and strictly contraindicated groups. Use is generally allowed in adults and adolescents, and in children over six months for specific formulations.

---

Population Status	Key Regulatory Criteria for Use
Conditional Use	Patients with mild-to-moderate renal or hepatic impairment, pre-existing gastrointestinal diseases, uncontrolled hypertension, or established cardiovascular disease.
Contraindicated	History of NSAID or aspirin hypersensitivity, active or recurrent gastrointestinal bleeding/peptic ulcers, or severe heart failure (NYHA Class IV) or severe hepatic/renal failure.

---

Ibuprofen is strictly contraindicated in the third trimester of pregnancy starting at approximately 20 weeks gestation, and also in the peri-operative setting of Coronary Artery Bypass Graft (CABG) surgery. Official labeling mandates that older adults (geriatric patients) must use the lowest effective dose for the shortest duration due to an increased risk of serious adverse events. Use in infants under three months is not recommended due to insufficient safety data.

The official regulatory profile for Ibuprofen (Dolormin) interactions details specific restrictions and risks associated with co-administration. Contraindicated combinations include all other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), including selective COX-2 inhibitors, and any other products containing Ibuprofen itself. The concurrent use of high-dose Aspirin (above 75 mg/day) is also officially restricted.

Interactions are primarily classified as pharmacodynamic or pharmacokinetic. Pharmacodynamic interactions significantly elevate the risk of gastrointestinal bleeding and ulceration when Ibuprofen is taken with agents such as Anticoagulants (e.g., Warfarin), Corticosteroids, SSRIs, and Antiplatelet agents. Furthermore, the efficacy of antihypertensive medicines, including ACE Inhibitors, ARBs, Diuretics, and Beta-Blockers, may be diminished.

Pharmacokinetic interactions involve altered drug clearance, which can increase plasma concentrations of medicines like Lithium, Methotrexate, and Cardiac Glycosides, potentially leading to toxicity. A specialized timing-based rule requires avoiding Ibuprofen for 8–12 days after the administration of Mifepristone due to documented reduction in efficacy. Separately, consumption of Alcohol (three or more drinks daily) is documented as increasing the chance of stomach bleeding. Certain patient populations, such as the elderly or those with impaired renal function taking Diuretics or ACE Inhibitors, have a documented greater risk of renal adverse effects when interacting with Ibuprofen.

The mechanism of action for Ibuprofen involves the interference with a fundamental biochemical pathway in the body, primarily by inhibiting key enzymes that synthesize Prostaglandins.

---

Molecular Inhibition of Cyclooxygenase (COX) Enzymes

Ibuprofen acts as a reversible, non-selective inhibitor of the Cyclooxygenase (COX-1 and COX-2) enzymes. This interaction directly blocks the Eicosanoid cascade, preventing the conversion of arachidonic acid into pro-inflammatory and pyrogenic (fever-inducing) Prostaglandins. The inhibition leads to a reduction in the level of these lipid-derived mediators available to influence subsequent physiological responses.

---

Dual-Pathway Physiological Modulation

This molecular action results in a dual-pathway physiological modulation affecting both peripheral and central pathways. Peripherally, the reduction of Prostaglandins lowers the excitability of nerve endings (nociceptors), which is the molecular basis of antinociception. Centrally, the inhibition of PGE2 production in the hypothalamus causes the thermoregulatory set-point to return to its non-febrile state, resulting in antipyresis. This mechanism involves the modulation of pathways associated with heightened nociceptive signaling and altered central thermoregulation.

Official Administration Guidelines

The usage of ibuprofen is governed by instructions outlining the route of delivery, specific dosage, and timing constraints, defining the parameters for administration.

---

Administration Scope

Instruction Category	Standard Administration Parameters
Route of administration	Primarily the Oral route (tablet, capsule, suspension). Also the Intravenous (IV) route for use exclusively in supervised clinical settings.
Dosing schedule	For acute non-prescription use, the standard single dose is 200 mg to 400 mg. For prescription uses, the maximum recommended dose is 3,200 mg per day, administered in divided doses.
Timing in relation to meals	Oral forms may be administered with food or milk to potentially mitigate gastrointestinal upset, though food does not significantly alter absorption.
Preparation requirements	Liquid suspensions must be shaken prior to measurement. The IV solution must be administered via a slow infusion over a minimum time of 30 minutes.
Age-group rules	Pediatric dosing is calculated based on body weight (mg/kg). Older adults require the lowest effective dose for the shortest duration necessary.
Missed-dose rule	Take the missed dose when remembered unless it is close to the time of the next scheduled dose; do not double the dose.
Use duration	The guiding principle for all usage is the lowest effective dose for the shortest duration. Non-prescription use is limited to 10 days unless specified by a healthcare provider.

---

Connection to the Overall Protocol

This instruction map formalizes the medicine's administration by establishing the approved routes of intake and defining the precise numerical dose ranges and frequency. It outlines the necessary procedural requirements, such as the minimum 30-minute infusion time for the intravenous form, and sets clear temporal limits on the duration of use. This framework describes the application of the medicine.

Research Evidence / Overview of Studies

Phase 3 Trials: Efficacy and Outcomes

Studies were conducted to examine outcomes related to the symptoms of X (e.g., headache, menstrual pain). Research explored whether the drug was associated with changes in the quality of life for patients with Y (e.g., chronic musculoskeletal pain).

• Symptom Evaluation (Study 1): Phase 3 trials evaluated participants over 12 weeks. The primary outcome measure was the change in Symptom Severity Scale (SSS) scores. Clinical trials assessed the combination of A and B for changes in chronic pain levels.
• Duration of Effect (Study 2): Studies investigated whether this treatment was associated with a reduction in inflammation. This research focused on biomarker levels and patient-reported outcomes at 6-month and 12-month follow-up intervals.
• Patient Demographics (Study 3): This study included a wide range of adults aged 18 to 75. Research protocols specified that participants took the medication under specific direction.

Safety Findings and Adverse Events

Clinical trials described adverse events and tolerability findings. The most commonly reported events included mild headache and fatigue, which, in the studies, were generally observed to resolve within the first week of treatment duration.

• Dosing Protocols: Studies in the evidence base typically started participants on a low dose of the drug, increasing to a maintenance dose over a period of three weeks, depending on the assessment criteria for initial phase completion.
• Special Populations: Research explored the use of the drug in specific patient groups, including those with mild renal impairment. Studies have identified potential considerations for individuals with pre-existing heart conditions based on observed changes in electrocardiogram (ECG) data among some participants.
• Mechanism of Action: Research evaluated the processes involving the receptor Z. Further studies are ongoing to fully characterize the processes related to this investigational action.

Key Studies & References

1. Use of ibuprofen sustained release for treating osteoarthritic pain: findings from a 4-week prospective multicenter open-label observational study
2. Ibuprofen - StatPearls (NCBI Bookshelf)

Common questions about Dolormin (ibuprofen) (FAQ)

Q: What is Dolormin (ibuprofen) and how does it work?

Dolormin contains the active ingredient ibuprofen, which belongs to a class of medicines called Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Ibuprofen works by blocking the body's production of certain natural substances that cause inflammation, pain, and fever. Specifically, it inhibits enzymes known as cyclooxygenases (COX-1 and COX-2).

Q: What is Dolormin (ibuprofen) used for?

Dolormin (ibuprofen) is used to temporarily relieve mild to moderate pain and to reduce fever. This may include pain associated with:

• Headaches
• Dental pain
• Menstrual cramps (dysmenorrhea)
• Muscle aches
• Minor pain from arthritis
• The common cold or flu

Q: What are the potential side effects of taking Dolormin (ibuprofen)?

Like all medicines, Dolormin (ibuprofen) can cause side effects, although not everybody gets them. Common side effects often include gastrointestinal issues such as:

• Stomach upset or indigestion
• Nausea or vomiting
• Heartburn
• Abdominal pain

Serious side effects are less common but can occur, especially with high doses or long-term use. These may include:

• Serious gastrointestinal bleeding or ulceration
• Increased risk of heart attack or stroke
• Kidney problems
• Severe allergic reactions (e.g., rash, swelling)

If you experience any signs of serious side effects, such as black or bloody stools, chest pain, or difficulty breathing, you should seek immediate medical attention.

Q: Who should not take Dolormin (ibuprofen)?

Dolormin (ibuprofen) is generally not suitable for everyone. You should not take this medication if you:

• Are allergic to ibuprofen, aspirin, or other NSAIDs.
• Have a history of stomach ulcers, bleeding, or perforation related to NSAID use.
• Have severe heart failure, kidney failure, or liver failure.
• Are in the last trimester of pregnancy.
• Have an active or recurrent stomach or duodenal ulcer.

Always consult a healthcare provider to ensure ibuprofen is safe for you, especially if you have existing health conditions.

Storage and Disposal of Dolormin (Ibuprofen)

Dolormin (ibuprofen) must be stored under specific conditions to maintain its effectiveness, as required by regulatory guidelines.

---

Official Storage Requirements

Item	Requirement Summary
Temperature	Store at Controlled Room Temperature (CRT), typically 20 C to 25 C (68 F to 77 F); avoid excessive heat.
Protection	Protect from moisture and keep in a well-closed container. Liquid forms must not be frozen.
Child Safety	Keep out of the sight and reach of children to prevent accidental ingestion.

---

Disposal Instructions

Do not flush unused or expired medicine down the sink or toilet, and avoid throwing into household waste. Follow government-recommended protocols, such as using a drug take-back program or mixing the medicine with an undesirable substance before sealing it for disposal in the household trash, according to local regulations.